Drug maker Cephalon on Monday completed a previously announced $425 million civil settlement with federal authorities over off-label drug marketing. Cephalon Inc. marketed three drugs for uses other than those for which they are federall approved, authorities…

See the rest here:
Cephalon to pay $425M for improper drug marketing